期刊文献+

低度恶性非霍奇金淋巴瘤37例化疗疗效观察 被引量:1

Chemotherapeutic Effects in 37 Cases with Non-Hodgkin's Lymphoma
下载PDF
导出
摘要 对37例经病理论断为低度恶性非霍奇金淋巴瘤患者进行了临床疗效分析,对Ⅰ、Ⅱ期患者给予全身化疗加肿瘤灶局部放疗,Ⅲ、Ⅳ期患者给予以全身化疗为主的治疗。治疗结果:Ⅱ期的治疗效果好于Ⅲ、Ⅳ期;A组的治疗效果好于B组。完全缓解(CR)率35.1%,部分缓解(PR)率27.0%,有效率(CR+PR)62.1%。认为:低度恶性非霍奇金淋巴瘤虽有较长的生存期,但采用标准方案治疗,仍不能长或缓解,且化疗的缓解率低于中、高度恶性非霍奇金淋巴瘤。 This paper analysed therapeutic effects in 37 cases pathologically confirmed as low grade nonHodgkin's lymphoma patients of stag Ⅰ ~ Ⅱ were treated with systemic chemotherapy plus local radiotherapy.Patients of stage Ⅲ ~ Ⅳ were treated with systemic chemotherapy. Therapeutic results revealed that complete remissbo (CR) rate was 35. 1%, partial remission (PR) rate was 27. 0%. Respose rate (CR+PR) was 62. 1 %.Low grade non-Hodgkin' s lymphoma had long term overall survival but didn't show long term remission. The remission rate of low grade non- Hodgkin's lymphoma was lower than that of intermediate and high grade nonHodgkin's lymphoma;The therapeutic effect of stuge Ⅱ was better than that of stuge Ⅲ ~ Ⅳ; The therapeutic effect of A group was better than that of the B group.
作者 徐卫
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 1999年第3期222-224,共3页 Journal of Nanjing Medical University(Natural Sciences)
关键词 非霍奇金淋巴瘤 治疗 诊断 non-Hodgkin's lymphoma therapy
  • 相关文献

参考文献5

  • 1李同度(译).临床肿瘤(第1版)[M].合肥:安徽科学技术出版社,1995.360.
  • 2第四届全国淋巴瘤学术座谈会技术组.1985年成都会议修订非霍奇金淋巴瘤工作分类方案及诊断指标[J].肿瘤,1985,5:277-277.
  • 3李同度(译),临床肿瘤,1995年,360页
  • 4张之南,血液病诊断及疗效标准,1991年,301页
  • 5第四届全国淋巴瘤学术座谈会技术组,肿瘤,1985年,5卷,277页

共引文献3

同被引文献8

  • 1余英豪,陈为民.低度恶性淋巴瘤的治疗进展[J].国外医学(输血及血液学分册),1996,19(2):105-107. 被引量:1
  • 2Lenz G,Dreyling M,Schiegnitz F,et al.Moderate increase of secondary hematologic malignancies after myeloablative radiochemotheraphy and autologous stem-cell transplantation in patients with indolent lymphoma:results of a prospective randomized trail of Low Grade Lymphoma Study Group[J].J Clin Oncol,2004,22(24):4926-4933.
  • 3Hendry L,Bowen A,Matutes E,et al.Fludarabine,cyclophosphamide and mitoxantone in relapsed or refractory choronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma[J].Leuk Lymphoma,2004,45 (5):945-950.
  • 4Ma SY,Au WY,Chim CS,et al.Fludarabine,mitoxantone and dexamethasone in the treatment of indolent B-and T-cell lymphoid malignancies in chinese patients[J].Br J Haematol,2004,124(6):754-761.
  • 5Di Bella N,Reynolds C,Faragher D,et al.An open-label pilot study of pentostatin,mitoxantone and rituximab in patients with previously untreated stage Ⅲ or Ⅳ low grade non-Hodgkin's lymphoma[J].Cancer,2005,103(5):978-984.
  • 6De Vries EG,Greidanus J,Mulder NH,et al.A phase Ⅰ and pharmacokinetic study with 21-day continuous infusional epriubicin[J].J Clin Oncol,1987,5(9):1445-1451.
  • 7周立强,王奇璐,冯奉仪,黄一容,顾大中,孙燕.低度恶性淋巴瘤64例临床疗效总结分析[J].实用肿瘤杂志,1998,13(6):348-349. 被引量:1
  • 8李晓凤,毋永娟,鲍力,梁秀芳,巴彩霞.应用化疗泵持续滴注5-Fu联合CF和HCPT治疗消化系肿瘤的疗效观察[J].临床肿瘤学杂志,2003,8(4):261-262. 被引量:8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部